Newsletter - Banner

Breadcrumb

Asset Publisher

Sepsis: testing before starting treatment is essential

Timely administration of appropriate antibiotics is essential to prevent death in patients with severe infections. Can healthcare teams “skip” drawing blood for bacterial cultures?

A close look at the progression of cells from normal to tumour

How exactly does a normal cell become a tumour?

How Salmonella tackles cellular defense mechanisms

Researchers uncover new protein that plays key role in bacterial infections

Strong criteria for diagnosing sarcopenia

Scientists propose diagnostic tools to identify, and possibly limit, the effects of sarcopenia, a disease that significantly reduces the quality of life of the aging population

Move to single-patient rooms at MUHC’s Glen site resulted in immediate, dramatic and long-lasting decrease of infection rates

Rates of colonization of two health-associated infections tumbled soon after historic hospital move

Montréal sans HépC: a fight to eliminate HCV in Montreal

Marina Klein co-leads initiative to make Montreal the first city in North America to eliminate hepatitis C

What is safe sedation in the ICU?

Dr. Yoanna Skrobik is co-author of an editorial in the New England Journal of Medicine

Can breastfeeding reduce mothers’ heart risk?

Dr. Natalie Dayan studies how heart problems in pregnant women can sometimes impact them for life

Air pollution speeds up ageing of the lungs and increases COPD risk

Lung function normally declines as we age, but a new study suggests that air pollution may contribute to this process

Gut bacteria associated with chronic widespread pain for first time

People with fibromyalgia show variations in microbiome composition

Pregnancy-specific anxiety may impact how long a woman exclusively breastfeeds her child

A longitudinal study led by RI-MUHC researcher Deborah Da Costa investigates an important predictor of pregnancy outcomes

A Quebec first: Research chair in women's heart health

Heart & Stroke and McGill University to create Early-Career Professorship in Women’s Heart Health

$27.9M to develop novel therapeutics options for patients with cancer

RI-MUHC is part of a Quebec-wide collaborative effort to provide oncology innovation and discovery pipeline

Patient empowerment app Opal wins Prix d'excellence honour

Technology and patient insight at the heart of innovative patient portal developed at the MUHC

Guidelines for managing anaphylaxis in children need an update

New study shows that pre-hospital treatment with epinephrine has the highest protective effect against uncontrolled allergic reaction

Canadian researchers on promising path towards developing flu treatment using lipid target

A team of scientists from the RI-MUHC recently identified a target to “tone down” the hyperactive immunity to influenza infection

Widespread off-label use of epilepsy medications could put some patients at risk

Despite limited proven efficacy, gabapentinoids are frequently prescribed to treat pain

Harnessing the body’s power in fight against cancer

Immunotherapy has provided lung cancer patients with real hope of recovery

Team from RI-MUHC and Lunenfeld-Tanenbaum Research Institute “follow a gut feeling” and discover a new stem cell

The human body has a remarkable ability to repair and renew itself. However, as we all know, our regenerative capacity quickly dwindles once we reach adulthood.

Children in Quebec are not diagnosed early enough with type 1 diabetes

A study reveals a rise in the number of children presenting a life-threatening complication at diagnosis.

See Archive - What's New